DENTSPLY SIRONA (NASDAQ:XRAY) Earns Outperform Rating from Barrington Research

Barrington Research reaffirmed their outperform rating on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a report published on Friday, Benzinga reports. They currently have a $36.00 price target on the medical instruments supplier’s stock.

Several other analysts have also commented on XRAY. Stifel Nicolaus cut their target price on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a hold rating for the company in a research note on Thursday, July 18th. Needham & Company LLC restated a buy rating and set a $34.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, August 20th. Robert W. Baird cut their price target on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a neutral rating on the stock in a report on Monday, July 22nd. Finally, Evercore ISI cut their price target on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an outperform rating on the stock in a report on Tuesday, July 9th. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of Moderate Buy and an average target price of $33.22.

DENTSPLY SIRONA Stock Down 2.3 %

XRAY stock opened at $26.29 on Friday. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57. The firm’s 50-day moving average is $25.56 and its two-hundred day moving average is $27.82. DENTSPLY SIRONA has a 52 week low of $23.58 and a 52 week high of $37.60. The company has a market capitalization of $5.46 billion, a price-to-earnings ratio of -59.75, a price-to-earnings-growth ratio of 1.25 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing the consensus estimate of $0.50 by ($0.01). DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The business had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. During the same period in the prior year, the company earned $0.51 earnings per share. The firm’s revenue for the quarter was down 4.3% on a year-over-year basis. On average, analysts forecast that DENTSPLY SIRONA will post 1.99 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 11th. Stockholders of record on Friday, September 27th will be paid a dividend of $0.16 per share. The ex-dividend date is Friday, September 27th. This represents a $0.64 annualized dividend and a dividend yield of 2.43%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -145.45%.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of DENTSPLY SIRONA during the 2nd quarter worth $1,689,000. Sanctuary Advisors LLC bought a new stake in shares of DENTSPLY SIRONA during the 2nd quarter worth $481,000. Teachers Retirement System of The State of Kentucky boosted its holdings in shares of DENTSPLY SIRONA by 264.5% during the 2nd quarter. Teachers Retirement System of The State of Kentucky now owns 70,598 shares of the medical instruments supplier’s stock worth $1,758,000 after buying an additional 51,228 shares during the period. Brandes Investment Partners LP boosted its holdings in shares of DENTSPLY SIRONA by 102.7% during the 2nd quarter. Brandes Investment Partners LP now owns 46,638 shares of the medical instruments supplier’s stock worth $1,166,000 after buying an additional 23,626 shares during the period. Finally, Creative Planning boosted its holdings in shares of DENTSPLY SIRONA by 53.9% during the 2nd quarter. Creative Planning now owns 16,540 shares of the medical instruments supplier’s stock worth $412,000 after buying an additional 5,793 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.